Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1995 Apr;221(4):420–426. doi: 10.1097/00000658-199504000-00014

Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism.

K Rouse 1, E Nwokedi 1, J E Woodliff 1, J Epstein 1, V S Klimberg 1
PMCID: PMC1234593  PMID: 7726679

Abstract

OBJECTIVE: Chemotherapy doses are limited by toxicity to normal tissues. Intravenous glutamine protects liver cells from oxidant injury by increasing intracellular glutathione (GSH) content. The authors hypothesized that supplemental oral glutamine (GLN) would increase the therapeutic index of methotrexate (MTX) by improving host tolerance through changes in glutathione metabolism. The authors examined the effects of oral glutamine on tumor and host glutathione metabolism and response to methotrexate. METHODS: Thirty-six 300-g Fischer 344 rats were implanted with fibrosarcomas. On day 21 after implantation, rats were randomized to receive isonitrogenous isocaloric diets containing 1 g/kg/day glutamine or glycine (GLY) by gavage. On day 23 after 2 days of prefeeding, rats were randomized to one of the following four groups receiving an intraperitoneal injection of methotrexate (20 mg/kg) or saline (CON): GLN+MTX, GLY+MTX, GLN-CON, or GLY-CON. On day 24, rats were killed and studied for arterial glutamine concentration, tumor volume, kidney and gut glutaminase activity, and glutathione content (tumor, gut, heart, liver, muscle, kidney, and lung). RESULTS: Provision of the glutamine-enriched diets to rats receiving MTX decreased tumor glutathione (2.38 +/- 0.17 in GLN+MTX vs. 2.92 +/- 0.20 in GLY+MTX, p < 0.05), whereas increasing or maintaining host glutathione stores (in gut, 2.60 +/- 0.28 in GLN+MTX vs. 1.93 +/- 0.18; in GLY+MTX, p < 0.05). Depressed glutathione levels in tumor cells increases susceptibility to chemotherapy. Significantly decreased glutathione content in tumor cells in the GLN+MTX group correlated with enhanced tumor volume loss (-0.8 +/- 1.0 mL in GLN+MTX vs. +9.5 +/- 2.0 mL in GLY+MTX, p < 0.05). CONCLUSION: These data suggest that oral glutamine supplementation will enhance the selectivity of antitumor drugs by protecting normal tissues from and possibly sensitizing tumor cells to chemotherapy treatment-related injury.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrick B. A., Nathan C. F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res. 1984 Oct;44(10):4224–4232. [PubMed] [Google Scholar]
  2. Askanazi J., Furst P., Michelsen C. B., Elwyn D. H., Vinnars E., Gump F. E., Stinchfield F. E., Kinney J. M. Muscle and plasma amino acids after injury: hypocaloric glucose vs. amino acid infusion. Ann Surg. 1980 Apr;191(4):465–472. doi: 10.1097/00000658-198004000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chan H., Evans W. E., Pratt C. B. Recovery from toxicity associated with high-dose methotrexate: prognostic factors. Cancer Treat Rep. 1977 Aug;61(5):797–804. [PubMed] [Google Scholar]
  4. Chen M. K., Salloum R. M., Austgen T. R., Bland J. B., Bland K. I., Copeland E. M., 3rd, Souba W. W. Tumor regulation of hepatic glutamine metabolism. JPEN J Parenter Enteral Nutr. 1991 Mar-Apr;15(2):159–164. doi: 10.1177/0148607191015002159. [DOI] [PubMed] [Google Scholar]
  5. Griffith O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980 Jul 15;106(1):207–212. doi: 10.1016/0003-2697(80)90139-6. [DOI] [PubMed] [Google Scholar]
  6. Hryniuk W. M. Average relative dose intensity and the impact on design of clinical trials. Semin Oncol. 1987 Mar;14(1):65–74. [PubMed] [Google Scholar]
  7. Kapadia C. R., Colpoys M. F., Jiang Z. M., Johnson D. J., Smith R. J., Wilmore D. W. Maintenance of skeletal muscle intracellular glutamine during standard surgical trauma. JPEN J Parenter Enteral Nutr. 1985 Sep-Oct;9(5):583–589. doi: 10.1177/0148607185009005583. [DOI] [PubMed] [Google Scholar]
  8. Kawamura I., Moldawer L. L., Keenan R. A., Batist G., Bothe A., Jr, Bistrian B. R., Blackburn G. L. Altered amino acid kinetics in rats with progressive tumor growth. Cancer Res. 1982 Mar;42(3):824–829. [PubMed] [Google Scholar]
  9. Klimberg V. S., Pappas A. A., Nwokedi E., Jensen J. C., Broadwater J. R., Lang N. P., Westbrook K. C. Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg. 1992 Nov;127(11):1317–1320. doi: 10.1001/archsurg.1992.01420110063013. [DOI] [PubMed] [Google Scholar]
  10. Klimberg V. S., Salloum R. M., Kasper M., Plumley D. A., Dolson D. J., Hautamaki R. D., Mendenhall W. R., Bova F. C., Bland K. I., Copeland E. M., 3rd Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg. 1990 Aug;125(8):1040–1045. doi: 10.1001/archsurg.1990.01410200104017. [DOI] [PubMed] [Google Scholar]
  11. Klimberg V. S., Souba W. W., Dolson D. J., Salloum R. M., Hautamaki R. D., Plumley D. A., Mendenhall W. M., Bova F. J., Khan S. R., Hackett R. L. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer. 1990 Jul 1;66(1):62–68. doi: 10.1002/1097-0142(19900701)66:1<62::aid-cncr2820660113>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  12. Klimberg V. S., Souba W. W., Salloum R. M., Plumley D. A., Cohen F. S., Dolson D. J., Bland K. I., Copeland E. M., 3rd Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. J Surg Res. 1990 Apr;48(4):319–323. doi: 10.1016/0022-4804(90)90066-b. [DOI] [PubMed] [Google Scholar]
  13. Kovacević Z., Morris H. P. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res. 1972 Feb;32(2):326–333. [PubMed] [Google Scholar]
  14. Kovacević Z. The pathway of glutamine and glutamate oxidation in isolated mitochondria from mammalian cells. Biochem J. 1971 Dec;125(3):757–763. doi: 10.1042/bj1250757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Meredith M. J., Williams G. M. Intracellular glutathione cycling by gamma-glutamyl transpeptidase in tumorigenic and nontumorigenic cultured rat liver cells. J Biol Chem. 1986 Apr 15;261(11):4986–4992. [PubMed] [Google Scholar]
  17. Nirenberg A., Mosende C., Mehta B. M., Gisolfi A. L., Rosen G. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treat Rep. 1977 Aug;61(5):779–783. [PubMed] [Google Scholar]
  18. Orlowski M., Wilk S. Intermediates of the gamma-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and gamma-glutamyl amino acids. Eur J Biochem. 1975 May 6;53(2):581–590. doi: 10.1111/j.1432-1033.1975.tb04101.x. [DOI] [PubMed] [Google Scholar]
  19. Pinkus L. M., Windmueller H. G. Phosphate-dependent glutaminase of small intestine: localization and role in intestinal glutamine metabolism. Arch Biochem Biophys. 1977 Aug;182(2):506–517. doi: 10.1016/0003-9861(77)90531-8. [DOI] [PubMed] [Google Scholar]
  20. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969 Mar;27(3):502–522. doi: 10.1016/0003-2697(69)90064-5. [DOI] [PubMed] [Google Scholar]
  21. Von Hoff D. D., Penta J. S., Helman L. J., Slavik M. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. Cancer Treat Rep. 1977 Jul;61(4):745–748. [PubMed] [Google Scholar]
  22. Welbourne T. C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979 Mar;57(3):233–237. doi: 10.1139/o79-029. [DOI] [PubMed] [Google Scholar]
  23. Wolf C. R., Lewis A. D., Carmichael J., Adams D. J., Allan S. G., Ansell D. J. The role of glutathione in determining the response of normal and tumor cells to anticancer drugs. Biochem Soc Trans. 1987 Aug;15(4):728–730. doi: 10.1042/bst0150728. [DOI] [PubMed] [Google Scholar]
  24. Yap H. Y., Blumenschein G. R., Yap B. S., Hortobagyi G. N., Tashima C. K., Wang A. Y., Benjamin R. S., Bodey G. P. High-dose methotrexate for advanced breast cancer. Cancer Treat Rep. 1979 May;63(5):757–761. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES